Department of Food Science and Technology, Faculty of Nutrition & Food Sciences, Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Curr Pharm Biotechnol. 2020;21(15):1576-1587. doi: 10.2174/1389201021666200516154833.
In recent decades, functional foods with ingredients comprising probiotics, prebiotics and postbiotics have been gaining a lot of attention from scientists. Probiotics and postbiotics are usually applied in pharmaceutical formulations and/or commercial food-based products. These bioactive agents can be associated with host eukaryotic cells and have a key role in maintaining and restoring host health. The review describes the concept of postbiotics, their quality control and potential applications in pharmaceutical formulations and commercial food-based products for health promotion, prevention of disease and complementary treatment. Despite the effectiveness of probiotic products, researchers have introduced the concept of postbiotic to optimize their beneficial effects as well as to meet the needs of consumers to provide a safe product. The finding of recent studies suggests that postbiotics might be appropriate alternative agents for live probiotic cells and can be applied in medical, veterinary and food practice to prevent and to treat some diseases, promote animal health status and develop functional foods. Presently scientific literature confirms that postbiotics, as potential alternative agents, may have superiority in terms of safety relative to their parent live cells, and due to their unique characteristics in terms of clinical, technological and economical aspects, can be applied as promising tools in the drug and food industry for developing health benefits, and therapeutic aims.
近几十年来,含有益生菌、益生元和后生元成分的功能性食品引起了科学家们的广泛关注。益生菌和后生元通常应用于药物制剂和/或商业食品产品。这些生物活性物质可以与宿主真核细胞相关联,在维持和恢复宿主健康方面发挥着关键作用。本文综述了后生元的概念、质量控制及其在促进健康、预防疾病和辅助治疗的药物制剂和商业食品产品中的潜在应用。尽管益生菌产品具有疗效,但研究人员引入了后生元的概念,以优化其有益作用,并满足消费者对提供安全产品的需求。最近的研究结果表明,后生元可能是活益生菌细胞的合适替代品,并可应用于医疗、兽医和食品实践中,以预防和治疗某些疾病,促进动物健康状况,并开发功能性食品。目前的科学文献证实,后生元作为潜在的替代物,在安全性方面可能优于其母体活细胞,并且由于其在临床、技术和经济方面的独特特征,可作为药物和食品工业中开发健康益处和治疗目标的有前途的工具。